about
CIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine.Overexpression and small molecule-triggered downregulation of CIP2A in lung cancerOverexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancerEthoxysanguinarine Induces Inhibitory Effects and Downregulates CIP2A in Lung Cancer Cells.Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.CIP2A regulates cell proliferation via the AKT signaling pathway in human lung cancer.Cancerous inhibitor of protein phosphatase 2A mediates bortezomib-induced autophagy in hepatocellular carcinoma independent of proteasome.Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cellsAfatinib induces apoptosis in NSCLC without EGFR mutation through Elk-1-mediated suppression of CIP2ACancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomyPP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cellsExpression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.CIP2A overexpression induces autoimmune response and enhances JNK signaling pathway in human lung cancer.CIP2A is a target of bortezomib in human triple negative breast cancer cells.CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations.Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis.CIP2A protein expression in high-grade, high-stage bladder cancer.Ets1 and Elk1 transcription factors regulate cancerous inhibitor of protein phosphatase 2A expression in cervical and endometrial carcinoma cells.Cancerous inhibitor of protein phosphatase 2A determines bortezomib-induced apoptosis in leukemia cells.Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells.Clinical significance of NUCB2 mRNA expression in prostate cancer.Cancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity.Expression of RABEX-5 and its clinical significance in prostate cancer.Protein phosphatase 2A: a target for anticancer therapy.Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC).PP2A-Mediated Anticancer Therapy.Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands.Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers.CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis.All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.Carfilzomib induces leukaemia cell apoptosis via inhibiting ELK1/KIAA1524 (Elk-1/CIP2A) and activating PP2A not related to proteasome inhibition.CIP2A is associated with multidrug resistance in cervical adenocarcinoma by a P-glycoprotein pathway.Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer.Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells.Cancerous inhibitor of protein phosphatase 2A promotes premature chromosome segregation and aneuploidy in prostate cancer cells through association with shugoshin.Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options.Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize NSCLC cells to cisplatin.Expression and prognostic significance of CIP2A in cutaneous malignant melanoma.CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion.CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.
P2860
Q27853345-B937CA83-D91C-4942-A88C-97FC75D660AAQ28478368-9053C530-6E6C-43D2-A325-3BE69215CDABQ28541215-CC4CFD2C-9A2E-4442-BA8D-9E96977D05FFQ33636463-ABEDD316-4A90-4539-A0AE-07E19296C110Q33895872-5E8A381B-5230-4287-B7F4-D4E5F47951D0Q34105248-F999A9F2-B401-4FCE-8497-16103ACBC557Q34577215-3A61EC71-CB7B-4892-BAB3-9A2A746EAD5EQ35000235-10ED174B-C591-4F3A-BBA7-A30295DAF5D0Q35273471-2152197F-F297-4668-8824-A0B93EBE2524Q35503680-402AFE65-8A25-4C5D-997A-296AB86E1C91Q35541658-FC000658-0388-42D4-A040-DFF1D030D646Q35653981-1BE04EA5-AF34-4359-8B30-B95C5841C99DQ35839042-A9880E71-1B23-490E-B457-287B222710C8Q36245640-332B99E6-B1BE-48DB-BD8D-E6036DE23146Q36260616-16625088-7D18-47AD-9F61-E8FA13FC474EQ36275673-6C6FFAD8-35F5-457A-AF85-9C3592546C35Q36530648-E3E833DE-FE39-4EA4-AB8E-CAC1D7E56C2BQ36777896-0C19FFD7-2C01-4806-B1F5-325CCB2C087AQ36805842-6DCB4446-5193-47D4-BD42-40F1B2C159CEQ36962531-AA8F7770-11DB-403A-BE45-51A7829D5A8BQ37116462-F3737539-553F-4B8B-9E8D-8953B8C70F5DQ37428639-44C071CB-7DF1-4414-8988-72109506E5CEQ37718867-730F8D2E-B203-4736-98E1-601F12987DBAQ38103646-5787BEB7-F5D0-41B4-9F4F-C0FFFF0643E3Q38107971-04311942-3720-4897-9CC4-00C32E48914BQ38168831-64AE9069-1C3D-4099-BAC3-F9C3BD679119Q38228491-242640D9-7F54-464B-BA81-BDE7FF8B54F1Q38335027-8A63C61E-B097-43AD-BB6B-9CFE4E95B34CQ38401447-B893EDE9-7E83-4443-B84D-FB7641BB1972Q38617799-18488B94-134A-46DA-8601-370D4228630EQ38710692-346BB67E-9124-4DF7-96CE-D0634D1CC0D3Q38832730-9AA750A8-49BF-4FB3-B886-F0D04555DBE9Q38869675-816C625E-61C2-483C-B058-7C3DCB908A9DQ38891984-20EEC634-72EC-46C5-A40A-26A1547FAB71Q38903935-1707403D-C433-42ED-95DA-0B1F9F1ECD09Q38904928-EF84B680-C3CF-48D9-9BCC-F5EF4E0A1188Q38990407-C827F30F-9FFE-45C8-BCFE-215DD4BDF61CQ39039799-550289A4-45B4-41E5-8CA5-088C225066E7Q39098575-1F148355-A604-4ED9-A49A-EFF0194AB5CFQ39218849-DE73A4B1-C7A8-4622-9CE4-DE14E926D30C
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CIP2A expression is increased in prostate cancer
@ast
CIP2A expression is increased in prostate cancer
@en
CIP2A expression is increased in prostate cancer
@en-gb
CIP2A expression is increased in prostate cancer
@nl
type
label
CIP2A expression is increased in prostate cancer
@ast
CIP2A expression is increased in prostate cancer
@en
CIP2A expression is increased in prostate cancer
@en-gb
CIP2A expression is increased in prostate cancer
@nl
prefLabel
CIP2A expression is increased in prostate cancer
@ast
CIP2A expression is increased in prostate cancer
@en
CIP2A expression is increased in prostate cancer
@en-gb
CIP2A expression is increased in prostate cancer
@nl
P2093
P2860
P356
P1476
CIP2A expression is increased in prostate cancer
@en
P2093
Ari Ristimäki
Marja-Riitta Väisänen
Markku H Vaarala
P2860
P2888
P356
10.1186/1756-9966-29-136
P407
P577
2010-01-01T00:00:00Z
P5875
P6179
1043024806